
Topic
Payer Policy
Medicare, commercial payer, PBM, and formulary-policy moves that shape launch curves and gross-to-net.

Pricing & Access· June 21, 2026 · 6 min read

Biosimilars· June 21, 2026 · 6 min read
Enbrel biosimilars compared: FDA approvals, patent litigation, and the 2029 market entry
By Ran Chen#Biosimilars#FDA Approval#TNF Inhibitor

Policy· June 21, 2026 · 7 min read
JAK Inhibitor Safety Labels: FDA Boxed Warnings vs EMA PRAC Restrictions
By Ran Chen#FDA Approval#Payer Policy#Label Warnings

Pricing & Access· June 9, 2026 · 10 min read
Awiqli coverage guide: insulin icodec access, PA criteria, and Part D pricing

Policy· June 9, 2026 · 12 min read
IRA Medicare drug negotiation third cycle: 15 drugs selected for 2028

Pricing & Access· June 6, 2026 · 11 min read
Blue Cross Blue Shield GLP-1 coverage policy and exclusions in 2026

Pricing & Access· June 6, 2026 · 11 min read
Express Scripts GLP-1 formulary: NPF exclusions, PA criteria, and 2026 coverage rules
By Ran Chen#GLP-1#Express Scripts#Prior Authorization

Pricing & Access· June 6, 2026 · 14 min read
GLP-1 reauthorization denial appeal: overturning PA renewal refusals
By Ran Chen#GLP-1#Prior Authorization#Payer Coverage

Pricing & Access· June 6, 2026 · 12 min read
Humana GLP-1 coverage: PA criteria, formulary tiers, and 2026 plan rules
By Ran Chen#GLP-1#Prior Authorization#Payer Coverage

Policy· June 6, 2026 · 12 min read
Medicaid GLP-1 coverage state by state: the 2026 landscape
By Ran Chen#GLP-1#Medicaid#Payer Coverage